993
Views
9
CrossRef citations to date
0
Altmetric
Review

Pathophysiology of Non-IgE-Mediated Food Allergy

, , &
Pages 431-446 | Published online: 29 Dec 2021

References

  • Nowak-Węgrzyn A, Katz Y, Mehr SS, Koletzko S. Non-IgE-mediated gastrointestinal food allergy. J Allergy Clin Immunol. 2015;135(5):1114–1124. doi:10.1016/j.jaci.2015.03.025
  • Connors L, O’Keefe A, Rosenfield L, Kim H. Non-IgE-mediated food hypersensitivity. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):56. doi:10.1186/s13223-018-0285-2
  • Gryboski JD. Gastrointestinal milk allergy in infants. Pediatrics. 1967;40(3):354–362. doi:10.1542/peds.40.3.354
  • Powell GK. Enterocolitis in low-birth-weight infants associated with milk and soy protein intolerance. J Pediatr. 1976;88(5):840–844. doi:10.1016/s0022-3476(76)81128-6
  • Powell GK. Milk- and soy-induced enterocolitis of infancy. Clinical features and standardization of challenge. J Pediatr. 1978;93(4):553–560. doi:10.1016/s0022-3476(78)80887-7
  • McDonald PJ, Powell GK, Goldblum RM. Serum D-xylose absorption tests: reproducibility and diagnostic usefulness in food-induced enterocolitis. J Pediatr Gastroenterol Nutr. 1982;1(4):533–536. doi:10.1097/00005176-198212000-00013
  • Sicherer SH, Eigenmann PA, Sampson HA. Clinical features of food protein-induced enterocolitis syndrome. J Pediatr. 1998;133(2):214–219. doi:10.1016/s0022-3476(98)70222-7
  • Nowak-Węgrzyn A, Chehade M, Groetch ME, et al. International consensus guidelines for the diagnosis and management of food protein-induced enterocolitis syndrome: executive summary-Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2017;139(4):1111–1126.e4. doi:10.1016/j.jaci.2016.12.966
  • Baker MG, Nowak-Wegrzyn A. Food protein-induced enterocolitis syndrome: epidemiology and comorbidities. Curr Opin Allergy Clin Immunol. 2020;20(2):168–174. doi:10.1097/aci.0000000000000615
  • Nowak-Wegrzyn A, Berin MC, Mehr S. Food protein-induced enterocolitis syndrome. J Allergy Clin Immunol Pract. 2020;8(1):24–35. doi:10.1016/j.jaip.2019.08.020
  • Hwang JB, Lee SH, Kang YN, Kim SP, Suh SI, Kam S. Indexes of suspicion of typical cow’s milk protein-induced enterocolitis. J Korean Med Sci. 2007;22(6):993–997. doi:10.3346/jkms.2007.22.6.993
  • Katz Y, Goldberg MR, Rajuan N, Cohen A, Leshno M. The prevalence and natural course of food protein-induced enterocolitis syndrome to cow’s milk: a large-scale, prospective population-based study. J Allergy Clin Immunol. 2011;127(3):647–53.e1–3. doi:10.1016/j.jaci.2010.12.1105
  • Mehr S, Frith K, Barnes EH, Campbell DE. Food protein-induced enterocolitis syndrome in Australia: a population-based study, 2012–2014. J Allergy Clin Immunol. 2017;140(5):1323–1330. doi:10.1016/j.jaci.2017.03.027
  • Nomura I, Morita H, Hosokawa S, et al. Four distinct subtypes of non-IgE-mediated gastrointestinal food allergies in neonates and infants, distinguished by their initial symptoms. J Allergy Clin Immunol. 2011;127(3):685–8.e1–8. doi:10.1016/j.jaci.2011.01.019
  • Maciag MC, Bartnikas LM, Sicherer SH, et al. A slice of Food Protein-Induced Enterocolitis Syndrome (FPIES): insights from 441 children with FPIES as provided by Caregivers in the International FPIES Association. J Allergy Clin Immunol Pract. 2020;8(5):1702–1709. doi:10.1016/j.jaip.2020.01.030
  • Vila L, García V, Rial MJ, Novoa E, Cacharron T. Fish is a major trigger of solid food protein-induced enterocolitis syndrome in Spanish children. J Allergy Clin Immunol Pract. 2015;3(4):621–623. doi:10.1016/j.jaip.2015.03.006
  • Sopo SM, Giorgio V, Dello Iacono I, Novembre E, Mori F, Onesimo R. A multicentre retrospective study of 66 Italian children with food protein-induced enterocolitis syndrome: different management for different phenotypes. Clin Exp Allergy. 2012;42(8):1257–1265. doi:10.1111/j.1365-2222.2012.04027.x
  • Mehr S, Frith K, Campbell DE. Epidemiology of food protein-induced enterocolitis syndrome. Curr Opin Allergy Clin Immunol. 2014;14(3):208–216. doi:10.1097/aci.0000000000000056
  • Nowak-Wegrzyn A, Sampson HA, Wood RA, Sicherer SH. Food protein-induced enterocolitis syndrome caused by solid food proteins. Pediatrics. 2003;111(4 Pt 1):829–835. doi:10.1542/peds.111.4.829
  • McDonald PJ, Goldblum RM, Van Sickle GJ, Powell GK. Food protein-induced enterocolitis: altered antibody response to ingested antigen. Pediatr Res. 1984;18(8):751–755. doi:10.1203/00006450-198408000-00016
  • Hwang JB, Sohn SM, Kim AS. Prospective follow-up oral food challenge in food protein-induced enterocolitis syndrome. Arch Dis Child. 2009;94(6):425–428. doi:10.1136/adc.2008.143289
  • Chung HL, Hwang JB, Park JJ, Kim SG. Expression of transforming growth factor beta1, transforming growth factor type I and II receptors, and TNF-alpha in the mucosa of the small intestine in infants with food protein-induced enterocolitis syndrome. J Allergy Clin Immunol. 2002;109(1):150–154. doi:10.1067/mai.2002.120562
  • Caubet JC, Ford LS, Sickles L, et al. Clinical features and resolution of food protein-induced enterocolitis syndrome: 10-year experience. J Allergy Clin Immunol. 2014;134(2):382–389. doi:10.1016/j.jaci.2014.04.008
  • Fogg MI, Brown-Whitehorn TA, Pawlowski NA, Spergel JM. Atopy patch test for the diagnosis of food protein-induced enterocolitis syndrome. Pediatr Allergy Immunol. 2006;17(5):351–355. doi:10.1111/j.1399-3038.2006.00418.x
  • Mehr S, Kakakios A, Frith K, Kemp AS. Food protein-induced enterocolitis syndrome: 16-year experience. Pediatrics. 2009;123(3):e459–64. doi:10.1542/peds.2008-2029
  • Ruffner MA, Ruymann K, Barni S, Cianferoni A, Brown-Whitehorn T, Spergel JM. Food protein-induced enterocolitis syndrome: insights from review of a large referral population. J Allergy Clin Immunol Pract. 2013;1(4):343–349. doi:10.1016/j.jaip.2013.05.011
  • Tan JA, Smith WB. Non-IgE-mediated gastrointestinal food hypersensitivity syndrome in adults. J Allergy Clin Immunol Pract. 2014;2(3):355–7.e1. doi:10.1016/j.jaip.2014.02.002
  • Goldman H, Proujansky R. Allergic proctitis and gastroenteritis in children. Clinical and mucosal biopsy features in 53 cases. Am J Surg Pathol. 1986;10(2):75–86. doi:10.1097/00000478-198602000-00001
  • Halpin TC, Byrne WJ, Ament ME. Colitis, persistent diarrhea, and soy protein intolerance. J Pediatr. 1977;91(3):404–407. doi:10.1016/s0022-3476(77)81308-5
  • Fontaine JL, Navarro J. Small intestinal biopsy in cows milk protein allergy in infancy. Arch Dis Child. 1975;50(5):357–362. doi:10.1136/adc.50.5.357
  • Jenkins HR, Pincott JR, Soothill JF, Milla PJ, Harries JT. Food allergy: the major cause of infantile colitis. Arch Dis Child. 1984;59(4):326–329. doi:10.1136/adc.59.4.326
  • Coello-Ramirez P, Larrosa-Haro A. Gastrointestinal occult hemorrhage and gastroduodenitis in cow’s milk protein intolerance. J Pediatr Gastroenterol Nutr. 1984;3(2):215–218. doi:10.1097/00005176-198403000-00008
  • Richards DG, Somers S, Issenman RM, Stevenson GW. Cow’s milk protein/soy protein allergy: gastrointestinal imaging. Radiology. 1988;167(3):721–723. doi:10.1148/radiology.167.3.3363128
  • Chung HL, Hwang JB, Kwon YD, Park MH, Shin WJ, Park JB. Deposition of eosinophil-granule major basic protein and expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the mucosa of the small intestine in infants with cow’s milk-sensitive enteropathy. J Allergy Clin Immunol. 1999;103(6):1195–1201. doi:10.1016/s0091-6749(99)70199-5
  • Powell GK, McDonald PJ, Van Sickle GJ, Goldblum RM. Absorption of food protein antigen in infants with food protein-induced enterocolitis. Dig Dis Sci. 1989;34(5):781–788. doi:10.1007/bf01540354
  • Kimura M, Ito Y, Shimomura M, et al. Cytokine profile after oral food challenge in infants with food protein-induced enterocolitis syndrome. Allergol Int. 2017;66(3):452–457. doi:10.1016/j.alit.2016.12.001
  • Caubet JC, Szajewska H, Shamir R, Nowak-Węgrzyn A. Non-IgE-mediated gastrointestinal food allergies in children. Pediatr Allergy Immunol. 2017;28(1):6–17. doi:10.1111/pai.12659
  • Goswami R, Blazquez AB, Kosoy R, Rahman A, Nowak-Węgrzyn A, Berin MC. Systemic innate immune activation in food protein-induced enterocolitis syndrome. J Allergy Clin Immunol. 2017;139(6):1885–1896.e9. doi:10.1016/j.jaci.2016.12.971
  • Mehr S, Lee E, Hsu P, et al. Innate immune activation occurs in acute food protein-induced enterocolitis syndrome reactions. J Allergy Clin Immunol. 2019;144(2):600–602.e2. doi:10.1016/j.jaci.2019.04.021
  • Berin MC. Advances in understanding immune mechanisms of food protein-induced enterocolitis syndrome. Ann Allergy Asthma Immunol. 2021;126(5):478–481. doi:10.1016/j.anai.2021.01.033
  • Mori F, Barni S, Cianferoni A, Pucci N, de Martino M, Novembre E. Cytokine expression in CD3+ cells in an infant with food protein-induced enterocolitis syndrome (FPIES): case report. Clin Dev Immunol. 2009;2009:679381. doi:10.1155/2009/679381
  • Morita H, Nomura I, Orihara K, et al. Antigen-specific T-cell responses in patients with non-IgE-mediated gastrointestinal food allergy are predominantly skewed to T(H)2. J Allergy Clin Immunol. 2013;131(2):590–2.e1–6. doi:10.1016/j.jaci.2012.09.005
  • Adel-Patient K, Lezmi G, Castelli FA, et al. Deep analysis of immune response and metabolic signature in children with food protein induced enterocolitis to cow’s milk. Clin Transl Allergy. 2018;8:38. doi:10.1186/s13601-018-0224-9
  • Caubet JC, Bencharitiwong R, Ross A, Sampson HA, Berin MC, Nowak-Węgrzyn A. Humoral and cellular responses to casein in patients with food protein-induced enterocolitis to cow’s milk. J Allergy Clin Immunol. 2017;139(2):572–583. doi:10.1016/j.jaci.2016.02.047
  • Berin MC, Lozano-Ojalvo D, Agashe C, Baker MG, Bird JA, Nowak-Wegrzyn A. Acute FPIES reactions are associated with an IL-17 inflammatory signature. J Allergy Clin Immunol. 2021;148(3):895–901.e6. doi:10.1016/j.jaci.2021.04.012
  • Savilahti E. Immunochemical study of the malabsorption syndrome with cow’s milk intolerance. Gut. 1973;14(6):491–501. doi:10.1136/gut.14.6.491
  • Konstantinou GN, Bencharitiwong R, Grishin A, et al. The role of casein-specific IgA and TGF-β in children with food protein-induced enterocolitis syndrome to milk. Pediatr Allergy Immunol. 2014;25(7):651–656. doi:10.1111/pai.12288
  • Shek LP, Bardina L, Castro R, Sampson HA, Beyer K. Humoral and cellular responses to cow milk proteins in patients with milk-induced IgE-mediated and non-IgE-mediated disorders. Allergy. 2005;60(7):912–919. doi:10.1111/j.1398-9995.2005.00705.x
  • Holbrook T, Keet CA, Frischmeyer-Guerrerio PA, Wood RA. Use of ondansetron for food protein-induced enterocolitis syndrome. J Allergy Clin Immunol. 2013;132(5):1219–1220. doi:10.1016/j.jaci.2013.06.021
  • Lake AM, Whitington PF, Hamilton SR. Dietary protein-induced colitis in breast-fed infants. J Pediatr. 1982;101(6):906–910. doi:10.1016/s0022-3476(82)80008-5
  • Xanthakos SA, Schwimmer JB, Melin-Aldana H, Rothenberg ME, Witte DP, Cohen MB. Prevalence and outcome of allergic colitis in healthy infants with rectal bleeding: a prospective cohort study. J Pediatr Gastroenterol Nutr. 2005;41(1):16–22. doi:10.1097/01.mpg.0000161039.96200.f1
  • Arvola T, Ruuska T, Keränen J, Hyöty H, Salminen S, Isolauri E. Rectal bleeding in infancy: clinical, allergological, and microbiological examination. Pediatrics. 2006;117(4):e760–8. doi:10.1542/peds.2005-1069
  • Martin VM, Virkud YV, Seay H, et al. Prospective assessment of pediatrician-diagnosed food protein-induced allergic proctocolitis by gross or occult blood. J Allergy Clin Immunol Pract. 2020;8(5):1692–1699.e1. doi:10.1016/j.jaip.2019.12.029
  • Martin VM, Virkud YV, Phadke NA, et al. Increased IgE-mediated food allergy with food protein-induced allergic proctocolitis. Pediatrics. 2020;146(3). doi:10.1542/peds.2020-0202
  • Ozen A, Gulcan EM, Ercan Saricoban H, Ozkan F, Cengizlier R. Food protein-induced non-immunoglobulin E-mediated allergic colitis in infants and older children: what cytokines are involved? Int Arch Allergy Immunol. 2015;168(1):61–68. doi:10.1159/000441471
  • Nowak-Węgrzyn A. Food protein-induced enterocolitis syndrome and allergic proctocolitis. Allergy Asthma Proc. 2015;36(3):172–184. doi:10.2500/aap.2015.36.3811
  • Machida HM, Catto smith AG, Gall DG, Trevenen C, Scott RB. Allergic colitis in infancy: clinical and pathologic aspects. J Pediatr Gastroenterol Nutr. 1994;19(1):22–26. doi:10.1097/00005176-199407000-00004
  • Meyer R, Chebar Lozinsky A, Fleischer DM, et al. Diagnosis and management of Non-IgE gastrointestinal allergies in breastfed infants-An EAACI position paper. Allergy. 2020;75(1):14–32. doi:10.1111/all.13947
  • Miceli sopo S, Monaco S, Bersani G, Romano A, Fantacci C. Proposal for management of the infant with suspected food protein-induced allergic proctocolitis. Pediatr Allergy Immunol. 2018;29(2):215–218. doi:10.1111/pai.12844
  • Kuitunen P, Visakorpi JK, Savilahti E, Pelkonen P. Malabsorption syndrome with cow’s milk intolerance. Clinical findings and course in 54 cases. Arch Dis Child. 1975;50(5):351–356. doi:10.1136/adc.50.5.351
  • Savilahti E. Food-induced malabsorption syndromes. J Pediatr Gastroenterol Nutr. 2000;30(Suppl):S61–6. doi:10.1097/00005176-200001001-00010
  • Iyngkaran N, Abdin Z, Davis K, et al. Acquired carbohydrate intolerance and cow milk protein-sensitive enteropathy in young infants. J Pediatr. 1979;95(3):373–378. doi:10.1016/s0022-3476(79)80509-0
  • Iyngkaran N, Yadav M, Boey CG, Lam KL. Severity and extent of upper small bowel mucosal damage in cow’s milk protein-sensitive enteropathy. J Pediatr Gastroenterol Nutr. 1988;7(5):667–674. doi:10.1097/00005176-198809000-00008
  • Carroccio A, Mansueto P, D’Alcamo A, Iacono G. Non-celiac wheat sensitivity as an allergic condition: personal experience and narrative review. Am J Gastroenterol. 2013;108(12):1845–52; quiz 1853. doi:10.1038/ajg.2013.353
  • Fritscher-Ravens A, Schuppan D, Ellrichmann M, et al. Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology. 2014;147(5):1012–20.e4. doi:10.1053/j.gastro.2014.07.046
  • Molnár K, Pintér P, Győrffy H, et al. Characteristics of allergic colitis in breast-fed infants in the absence of cow’s milk allergy. World j Gastroenterol. 2013;19(24):3824–3830. doi:10.3748/wjg.v19.i24.3824
  • Beyer K, Castro R, Birnbaum A, Benkov K, Pittman N, Sampson HA. Human milk-specific mucosal lymphocytes of the gastrointestinal tract display a TH2 cytokine profile. J Allergy Clin Immunol. 2002;109(4):707–713. doi:10.1067/mai.2002.122503
  • Kokkonen J, Haapalahti M, Laurila K, Karttunen TJ, Mäki M. Cow’s milk protein-sensitive enteropathy at school age. J Pediatr. 2001;139(6):797–803. doi:10.1067/mpd.2001.118882
  • Augustin MT, Kokkonen J, Karttunen TJ. Duodenal cytotoxic lymphocytes in cow’s milk protein sensitive enteropathy and coeliac disease. Scand J Gastroenterol. 2005;40(12):1398–1406. doi:10.1080/00365520510023765
  • Paajanen L, Vaarala O, Karttunen R, Tuure T, Korpela R, Kokkonen J. Increased IFN-gamma secretion from duodenal biopsy samples in delayed-type cow’s milk allergy. Pediatr Allergy Immunol. 2005;16(5):439–444. doi:10.1111/j.1399-3038.2005.00312.x
  • Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128(1):3–20.e6; quiz 21–2. doi:10.1016/j.jaci.2011.02.040
  • Chehade M, Jones SM, Pesek RD, et al. Phenotypic characterization of eosinophilic esophagitis in a large multicenter patient population from the consortium for food allergy research. J Allergy Clin Immunol Pract. 2018;6(5):1534–1544.e5. doi:10.1016/j.jaip.2018.05.038
  • Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol. 2004;113(1):11–28; quiz 29. doi:10.1016/j.jaci.2003.10.047
  • O’Shea KM, Aceves SS, Dellon ES, et al. Pathophysiology of Eosinophilic Esophagitis. Gastroenterology. 2018;154(2):333–345. doi:10.1053/j.gastro.2017.06.065
  • Dellon ES. Epidemiology of eosinophilic esophagitis. Gastroenterol Clin North Am. 2014;43(2):201–218. doi:10.1016/j.gtc.2014.02.002
  • Spergel JM, Book WM, Mays E, et al. Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr. 2011;52(3):300–306. doi:10.1097/MPG.0b013e3181eb5a9f
  • Jensen ET, Martin CF, Kappelman MD, Dellon ES. Prevalence of eosinophilic gastritis, gastroenteritis, and colitis: estimates from a national administrative database. J Pediatr Gastroenterol Nutr. 2016;62(1):36–42. doi:10.1097/mpg.0000000000000865
  • Rochman M, Azouz NP, Rothenberg ME. Epithelial origin of eosinophilic esophagitis. J Allergy Clin Immunol. 2018;142(1):10–23. doi:10.1016/j.jaci.2018.05.008
  • Cianferoni A, Jensen E, Davis CM. The role of the environment in eosinophilic esophagitis. J Allergy Clin Immunol Pract. 2021;9(9):3268–3274. doi:10.1016/j.jaip.2021.07.032
  • Kottyan LC, Parameswaran S, Weirauch MT, Rothenberg ME, Martin LJ. The genetic etiology of eosinophilic esophagitis. J Allergy Clin Immunol. 2020;145(1):9–15. doi:10.1016/j.jaci.2019.11.013
  • Kottyan LC, Davis BP, Sherrill JD, et al. Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nat Genet. 2014;46(8):895–900. doi:10.1038/ng.3033
  • Sleiman PM, Wang ML, Cianferoni A, et al. GWAS identifies four novel eosinophilic esophagitis loci. Nat Commun. 2014;5:5593. doi:10.1038/ncomms6593
  • Azouz NP, Ynga-Durand MA, Caldwell JM, et al. The antiprotease SPINK7 serves as an inhibitory checkpoint for esophageal epithelial inflammatory responses. Sci Transl Med. 2018;10(444). doi:10.1126/scitranslmed.aap9736
  • Mishra A, Hogan SP, Brandt EB, Rothenberg ME. IL-5 promotes eosinophil trafficking to the esophagus. J Immunol. 2002;168(5):2464–2469. doi:10.4049/jimmunol.168.5.2464
  • Mishra A, Wang M, Pemmaraju VR, et al. Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology. 2008;134(1):204–214. doi:10.1053/j.gastro.2007.10.002
  • Hogan SP, Mishra A, Brandt EB, Foster PS, Rothenberg ME. A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy. Proc Natl Acad Sci U S A. 2000;97(12):6681–6686. doi:10.1073/pnas.97.12.6681
  • Mishra A, Hogan SP, Lee JJ, Foster PS, Rothenberg ME. Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest. 1999;103(12):1719–1727. doi:10.1172/jci6560
  • Frischmeyer-Guerrerio PA, Guerrerio AL, Chichester KL, et al. Dendritic cell and T cell responses in children with food allergy. Clin Exp Allergy. 2011;41(1):61–71. doi:10.1111/j.1365-2222.2010.03606.x
  • Zuo L, Fulkerson PC, Finkelman FD, et al. IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway. J Immunol. 2010;185(1):660–669. doi:10.4049/jimmunol.1000471
  • Huang JJ, Joh JW, Fuentebella J, et al. Eotaxin and FGF enhance signaling through an extracellular signal-related kinase (ERK)-dependent pathway in the pathogenesis of Eosinophilic esophagitis. Allergy Asthma Clin Immunol. 2010;6(1):25. doi:10.1186/1710-1492-6-25
  • Davis BP, Stucke EM, Khorki ME, et al. Eosinophilic esophagitis-linked calpain 14 is an IL-13-induced protease that mediates esophageal epithelial barrier impairment. JCI Insight. 2016;1(4):e86355. doi:10.1172/jci.insight.86355
  • Litosh VA, Rochman M, Rymer JK, Porollo A, Kottyan LC, Rothenberg ME. Calpain-14 and its association with eosinophilic esophagitis. J Allergy Clin Immunol. 2017;139(6):1762–1771.e7. doi:10.1016/j.jaci.2016.09.027
  • Sherrill JD, Kc K, Wu D, et al. Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis. Mucosal Immunol. 2014;7(3):718–729. doi:10.1038/mi.2013.90
  • Wen T, Aronow BJ, Rochman Y, et al. Single-cell RNA sequencing identifies inflammatory tissue T cells in eosinophilic esophagitis. J Clin Invest. 2019;129(5):2014–2028. doi:10.1172/jci125917
  • Nhu QM, Aceves SS. Tissue remodeling in chronic eosinophilic esophageal inflammation: parallels in asthma and therapeutic perspectives. Front Med. 2017;4:128. doi:10.3389/fmed.2017.00128
  • Aceves SS, Newbury RO, Dohil R, Bastian JF, Broide DH. Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol. 2007;119(1):206–212. doi:10.1016/j.jaci.2006.10.016
  • Chehade M, Sampson HA, Morotti RA, Magid MS. Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2007;45(3):319–328. doi:10.1097/MPG.0b013e31806ab384
  • Tkachenko E, Rawson R, La E, et al. Rigid substrate induces esophageal smooth muscle hypertrophy and eosinophilic esophagitis fibrotic gene expression. J Allergy Clin Immunol. 2016;137(4):1270–1272.e1. doi:10.1016/j.jaci.2015.09.020
  • Prussin C, Lee J, Foster B. Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5(-) T(H)2 responses. J Allergy Clin Immunol. 2009;124(6):1326–32.e6. doi:10.1016/j.jaci.2009.09.048
  • Caldwell JM, Collins MH, Stucke EM, et al. Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome. J Allergy Clin Immunol. 2014;134(5):1114–1124. doi:10.1016/j.jaci.2014.07.026
  • Ashitani K, Tsuzuki Y, Yamaoka M, et al. Endoscopic features and diagnostic procedures of eosinophilic gastroenteritis. Internal Med. 2019;58(15):2167–2171. doi:10.2169/internalmedicine.2298-18
  • Desreumaux P, Bloget F, Seguy D, et al. Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis. Gastroenterology. 1996;110(3):768–774. doi:10.1053/gast.1996.v110.pm8608886
  • Pesek RD, Rothenberg ME. Eosinophilic gastrointestinal disease below the belt. J Allergy Clin Immunol. 2020;145(1):87–89.e1. doi:10.1016/j.jaci.2019.10.013
  • Pesek RD, Greuter T, Lopez-Nunez O, Bernieh A, Straumann A, Collins MH. Clinicopathologic correlations in eosinophilic gastrointestinal disorders. J Allergy Clin Immunol Pract. 2021;9(9):3258–3266. doi:10.1016/j.jaip.2021.06.002
  • Hirano I, Chan ES, Rank MA, et al. AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis. Gastroenterology. 2020;158(6):1776–1786. doi:10.1053/j.gastro.2020.02.038
  • Chehade M, Aceves SS. Treatment of eosinophilic esophagitis: diet or medication? J Allergy Clin Immunol Pract. 2021;9(9):3249–3256. doi:10.1016/j.jaip.2021.07.029
  • Gonsalves NP, Aceves SS. Diagnosis and treatment of eosinophilic esophagitis. J Allergy Clin Immunol. 2020;145(1):1–7. doi:10.1016/j.jaci.2019.11.011
  • Kagalwalla AF, Sentongo TA, Ritz S, et al. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2006;4(9):1097–1102. doi:10.1016/j.cgh.2006.05.026
  • McGowan EC, Platts-Mills TA. Eosinophilic esophagitis from an allergy perspective: how to optimally pursue allergy testing & dietary modification in the adult population. Curr Gastroenterol Rep. 2016;18(11):58. doi:10.1007/s11894-016-0531-z
  • Groetch M, Venter C, Skypala I, et al. Dietary therapy and nutrition management of eosinophilic esophagitis: a Work Group Report of the American Academy of Allergy, Asthma, and Immunology. J Allergy Clin Immunol Pract. 2017;5(2):312–324.e29. doi:10.1016/j.jaip.2016.12.026
  • Dellon ES, Peterson KA, Murray JA, et al. Anti-siglec-8 antibody for eosinophilic gastritis and duodenitis. N Engl J Med. 2020;383(17):1624–1634. doi:10.1056/NEJMoa2012047
  • Greuter T, Hirano I, Dellon ES. Emerging therapies for eosinophilic esophagitis. J Allergy Clin Immunol. 2020;145(1):38–45. doi:10.1016/j.jaci.2019.10.027
  • Hirano I, Dellon ES, Hamilton JD, et al. Efficacy of dupilumab in a Phase 2 randomized trial of adults with active eosinophilic esophagitis. Gastroenterology. 2020;158(1):111–122.e10. doi:10.1053/j.gastro.2019.09.042
  • Clayton F, Fang JC, Gleich GJ, et al. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology. 2014;147(3):602–609. doi:10.1053/j.gastro.2014.05.036
  • Zhang S, Assa’ad AH. Biologics in eosinophilic esophagitis. Curr Opin Allergy Clin Immunol. 2021;21(3):292–296. doi:10.1097/aci.0000000000000741
  • Rothenberg ME, Wen T, Greenberg A, et al. Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis. J Allergy Clin Immunol. 2015;135(2):500–507. doi:10.1016/j.jaci.2014.07.049
  • Hirano I, Collins MH, Assouline-Dayan Y, et al. RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis. Gastroenterology. 2019;156(3):592–603.e10. doi:10.1053/j.gastro.2018.10.051
  • Gann PH, Deaton RJ, McMahon N, et al. An anti-IL-13 antibody reverses epithelial-mesenchymal transition biomarkers in eosinophilic esophagitis: phase 2 trial results. J Allergy Clin Immunol. 2020;146(2):367–376.e3. doi:10.1016/j.jaci.2020.03.045
  • Choudhury S, Baker S. Eosinophilic esophagitis: the potential role of biologics in its treatment. Clin Rev Allergy Immunol. 2020;59(2):150–159. doi:10.1007/s12016-019-08749-6
  • Straumann A, Bussmann C, Conus S, Beglinger C, Simon HU. Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis. J Allergy Clin Immunol. 2008;122(2):425–427. doi:10.1016/j.jaci.2008.06.012
  • Straumann A, Hoesli S, Bussmann C, et al. Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis. Allergy. 2013;68(3):375–385. doi:10.1111/all.12096
  • Loizou D, Enav B, Komlodi-Pasztor E, et al. A pilot study of omalizumab in eosinophilic esophagitis. PLoS One. 2015;10(3):e0113483. doi:10.1371/journal.pone.0113483
  • Rocha R, Vitor AB, Trindade E, et al. Omalizumab in the treatment of eosinophilic esophagitis and food allergy. Eur J Pediatr. 2011;170(11):1471–1474. doi:10.1007/s00431-011-1540-4
  • Berin MC. Immunopathophysiology of food protein-induced enterocolitis syndrome. J Allergy Clin Immunol. 2015;135(5):1108–1113. doi:10.1016/j.jaci.2014.12.1948
  • Kelly KJ. Eosinophilic gastroenteritis. J Pediatr Gastroenterol Nutr. 2000;30(Suppl):S28–35. doi:10.1097/00005176-200001001-00005
  • Kuang FL, Legrand F, Makiya M, et al. Benralizumab for PDGFRA-negative hypereosinophilic syndrome. N Engl J Med. 2019;380(14):1336–1346. doi:10.1056/NEJMoa1812185
  • Stein ML, Collins MH, Villanueva JM, et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol. 2006;118(6):1312–1319. doi:10.1016/j.jaci.2006.09.007
  • Assa’ad AH, Gupta SK, Collins MH, et al. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology. 2011;141(5):1593–1604. doi:10.1053/j.gastro.2011.07.044
  • Straumann A, Conus S, Grzonka P, et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut. 2010;59(1):21–30. doi:10.1136/gut.2009.178558
  • Spergel JM, Rothenberg ME, Collins MH, et al. Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2012;129(2):456–63, 463.e1–3. doi:10.1016/j.jaci.2011.11.044
  • Markowitz JE, Jobe L, Miller M, Frost C, Laney Z, Eke R. Safety and efficacy of reslizumab for children and adolescents with eosinophilic esophagitis treated for 9 years. J Pediatr Gastroenterol Nutr. 2018;66(6):893–897. doi:10.1097/mpg.0000000000001840
  • Fuchs GJ 3rd. Efficacy of reslizumab for eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2018;67(4):e86. doi:10.1097/mpg.0000000000002087
  • Dellon ES, Collins MH, Rothenberg ME, et al. Long-term efficacy and tolerability of RPC4046 in an open-label extension trial of patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2021;19(3):473–483.e17. doi:10.1016/j.cgh.2020.03.036
  • Nhu QM, Chiao H, Moawad FJ, Bao F, Konijeti GG. The anti-α4β7 integrin therapeutic antibody for inflammatory bowel disease, vedolizumab, ameliorates eosinophilic esophagitis: a novel clinical observation. Am J Gastroenterol. 2018;113(8):1261–1263. doi:10.1038/s41395-018-0145-1
  • Taft TH, Mutlu EA. The potential role of vedolizumab in concomitant eosinophilic esophagitis and crohn’s disease. Clin Gastroenterol Hepatol. 2018;16(11):1840–1841. doi:10.1016/j.cgh.2018.06.022
  • Kim HP, Reed CC, Herfarth HH, Dellon ES. Vedolizumab treatment may reduce steroid burden and improve histology in patients with eosinophilic gastroenteritis. Clin Gastroenterol Hepatol. 2018;16(12):1992–1994. doi:10.1016/j.cgh.2018.03.024
  • Mendoza Alvarez LB, Liu X, Glover S. Treatment-resistant eosinophilic oesophagitis successfully managed with tofacitinib. BMJ Case Rep. 2019;12(12):e232558. doi:10.1136/bcr-2019-232558